These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 31002855)

  • 1. Predictive accuracy of the breast cancer genetic risk model based on eight common genetic variants: The BACkSIDE study.
    Danková Z; Žúbor P; Grendár M; Zelinová K; Jagelková M; Stastny I; Kapinová A; Vargová D; Kasajová P; Dvorská D; Kalman M; Danko J; Lasabová Z
    J Biotechnol; 2019 Jun; 299():1-7. PubMed ID: 31002855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of single nucleotide polymorphisms in FGF-RAS/MAP signalling cascade with breast cancer susceptibility.
    Dankova Z; Zubor P; Grendar M; Kapinova A; Zelinova K; Jagelkova M; Gondova A; Dokus K; Kalman M; Lasabova Z; Danko J
    Gen Physiol Biophys; 2017 Dec; 36(5):565-572. PubMed ID: 29372690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variants in FGFR2 and MAP3K1 are associated with the risk of familial and early-onset breast cancer in a South-American population.
    Jara L; Gonzalez-Hormazabal P; Cerceño K; Di Capua GA; Reyes JM; Blanco R; Bravo T; Peralta O; Gomez F; Waugh E; Margarit S; Ibañez G; Romero C; Pakomio J; Roizen G
    Breast Cancer Res Treat; 2013 Jan; 137(2):559-69. PubMed ID: 23225170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-penetrance susceptibility variants and postmenopausal oestrogen receptor positive breast cancer.
    Özgöz A; İçduygu FM; Yükseltürk A; ŞamlI H; Öztürk KH; Başkan Z
    J Genet; 2020; 99():. PubMed ID: 32366738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variants in FGFR2 and TNRC9 genes are associated with breast cancer risk in Pakistani women.
    Mazhar A; Jamil F; Bashir Q; Ahmad MS; Masood M; Tanvir I; Rashid N; Waheed A; Afzal MN; Tariq MA
    Mol Med Rep; 2016 Oct; 14(4):3443-51. PubMed ID: 27572905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases.
    Huijts PE; Vreeswijk MP; Kroeze-Jansema KH; Jacobi CE; Seynaeve C; Krol-Warmerdam EM; Wijers-Koster PM; Blom JC; Pooley KA; Klijn JG; Tollenaar RA; Devilee P; van Asperen CJ
    Breast Cancer Res; 2007; 9(6):R78. PubMed ID: 17997823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene-environment interactions in 7610 women with breast cancer: prospective evidence from the Million Women Study.
    Travis RC; Reeves GK; Green J; Bull D; Tipper SJ; Baker K; Beral V; Peto R; Bell J; Zelenika D; Lathrop M;
    Lancet; 2010 Jun; 375(9732):2143-51. PubMed ID: 20605201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer susceptibility variants alter risks in familial disease.
    Latif A; Hadfield KD; Roberts SA; Shenton A; Lalloo F; Black GC; Howell A; Evans DG; Newman WG
    J Med Genet; 2010 Feb; 47(2):126-31. PubMed ID: 19617217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of FGFR2, TNRC9, MAP3K1, LSP1, and 8q24 alleles in genetically enriched breast cancer patients versus elderly tumor-free women.
    Gorodnova TV; Kuligina ESh; Yanus GA; Katanugina AS; Abysheva SN; Togo AV; Imyanitov EN
    Cancer Genet Cytogenet; 2010 May; 199(1):69-72. PubMed ID: 20417875
    [No Abstract]   [Full Text] [Related]  

  • 10. Breast cancer genome-wide association studies: there is strength in numbers.
    Fanale D; Amodeo V; Corsini LR; Rizzo S; Bazan V; Russo A
    Oncogene; 2012 Apr; 31(17):2121-8. PubMed ID: 21996731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics.
    Garcia-Closas M; Hall P; Nevanlinna H; Pooley K; Morrison J; Richesson DA; Bojesen SE; Nordestgaard BG; Axelsson CK; Arias JI; Milne RL; Ribas G; González-Neira A; Benítez J; Zamora P; Brauch H; Justenhoven C; Hamann U; Ko YD; Bruening T; Haas S; Dörk T; Schürmann P; Hillemanns P; Bogdanova N; Bremer M; Karstens JH; Fagerholm R; Aaltonen K; Aittomäki K; von Smitten K; Blomqvist C; Mannermaa A; Uusitupa M; Eskelinen M; Tengström M; Kosma VM; Kataja V; Chenevix-Trench G; Spurdle AB; Beesley J; Chen X; ; ; Devilee P; van Asperen CJ; Jacobi CE; Tollenaar RA; Huijts PE; Klijn JG; Chang-Claude J; Kropp S; Slanger T; Flesch-Janys D; Mutschelknauss E; Salazar R; Wang-Gohrke S; Couch F; Goode EL; Olson JE; Vachon C; Fredericksen ZS; Giles GG; Baglietto L; Severi G; Hopper JL; English DR; Southey MC; Haiman CA; Henderson BE; Kolonel LN; Le Marchand L; Stram DO; Hunter DJ; Hankinson SE; Cox DG; Tamimi R; Kraft P; Sherman ME; Chanock SJ; Lissowska J; Brinton LA; Peplonska B; Klijn JG; Hooning MJ; Meijers-Heijboer H; Collee JM; van den Ouweland A; Uitterlinden AG; Liu J; Lin LY; Yuqing L; Humphreys K; Czene K; Cox A; Balasubramanian SP; Cross SS; Reed MW; Blows F; Driver K; Dunning A; Tyrer J; Ponder BA; Sangrajrang S; Brennan P; McKay J; Odefrey F; Gabrieau V; Sigurdson A; Doody M; Struewing JP; Alexander B; Easton DF; Pharoah PD
    PLoS Genet; 2008 Apr; 4(4):e1000054. PubMed ID: 18437204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer susceptibility alleles and ovarian cancer risk in 2 study populations.
    Gates MA; Tworoger SS; Terry KL; De Vivo I; Hunter DJ; Hankinson SE; Cramer DW
    Int J Cancer; 2009 Feb; 124(3):729-33. PubMed ID: 18973230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone-dependent effects of FGFR2 and MAP3K1 in breast cancer susceptibility in a population-based sample of post-menopausal African-American and European-American women.
    Rebbeck TR; DeMichele A; Tran TV; Panossian S; Bunin GR; Troxel AB; Strom BL
    Carcinogenesis; 2009 Feb; 30(2):269-74. PubMed ID: 19028704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians.
    Shan J; Mahfoudh W; Dsouza SP; Hassen E; Bouaouina N; Abdelhak S; Benhadjayed A; Memmi H; Mathew RA; Aigha II; Gabbouj S; Remadi Y; Chouchane L
    Breast Cancer Res Treat; 2012 Oct; 135(3):715-24. PubMed ID: 22910930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between rs2981582 polymorphism in the FGFR2 gene and the risk of breast cancer in Mexican women.
    Murillo-Zamora E; Moreno-Macías H; Ziv E; Romieu I; Lazcano-Ponce E; Angeles-Llerenas A; Pérez-Rodríguez E; Vidal-Millán S; Fejerman L; Torres-Mejía G
    Arch Med Res; 2013 Aug; 44(6):459-66. PubMed ID: 24054997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of FGFR2 gene polymorphism in women with breast cancer.
    Salehi Z; Afzali S; Shabanipour S; Rahimi A
    Cell Mol Biol (Noisy-le-grand); 2015 May; 61(2):94-7. PubMed ID: 26025410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between mitogen-activated protein kinase kinase kinase 1 rs889312 polymorphism and breast cancer risk: evidence from 59,977 subjects.
    Lu PH; Yang J; Li C; Wei MX; Shen W; Shi LP; Jiang ZY; Zhou N; Tao GQ
    Breast Cancer Res Treat; 2011 Apr; 126(3):663-70. PubMed ID: 20809358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-risk variants FGFR2, TNRC9 and LSP1 in German familial breast cancer patients.
    Hemminki K; Müller-Myhsok B; Lichtner P; Engel C; Chen B; Burwinkel B; Försti A; Sutter C; Wappenschmidt B; Hellebrand H; Illig T; Arnold N; Niederacher D; Dworniczak B; Deissler H; Kast K; Gadzicki D; Meitinger T; Wichmann HE; Kiechle M; Bartram CR; Schmutzler RK; Meindl A
    Int J Cancer; 2010 Jun; 126(12):2858-62. PubMed ID: 19856316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide association study identifies novel breast cancer susceptibility loci.
    Easton DF; Pooley KA; Dunning AM; Pharoah PD; Thompson D; Ballinger DG; Struewing JP; Morrison J; Field H; Luben R; Wareham N; Ahmed S; Healey CS; Bowman R; ; Meyer KB; Haiman CA; Kolonel LK; Henderson BE; Le Marchand L; Brennan P; Sangrajrang S; Gaborieau V; Odefrey F; Shen CY; Wu PE; Wang HC; Eccles D; Evans DG; Peto J; Fletcher O; Johnson N; Seal S; Stratton MR; Rahman N; Chenevix-Trench G; Bojesen SE; Nordestgaard BG; Axelsson CK; Garcia-Closas M; Brinton L; Chanock S; Lissowska J; Peplonska B; Nevanlinna H; Fagerholm R; Eerola H; Kang D; Yoo KY; Noh DY; Ahn SH; Hunter DJ; Hankinson SE; Cox DG; Hall P; Wedren S; Liu J; Low YL; Bogdanova N; Schürmann P; Dörk T; Tollenaar RA; Jacobi CE; Devilee P; Klijn JG; Sigurdson AJ; Doody MM; Alexander BH; Zhang J; Cox A; Brock IW; MacPherson G; Reed MW; Couch FJ; Goode EL; Olson JE; Meijers-Heijboer H; van den Ouweland A; Uitterlinden A; Rivadeneira F; Milne RL; Ribas G; Gonzalez-Neira A; Benitez J; Hopper JL; McCredie M; Southey M; Giles GG; Schroen C; Justenhoven C; Brauch H; Hamann U; Ko YD; Spurdle AB; Beesley J; Chen X; ; ; Mannermaa A; Kosma VM; Kataja V; Hartikainen J; Day NE; Cox DR; Ponder BA
    Nature; 2007 Jun; 447(7148):1087-93. PubMed ID: 17529967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between FGFR2 (rs2981582, rs2420946 and rs2981578) polymorphism and breast cancer susceptibility: a meta-analysis.
    Zhang Y; Zeng X; Liu P; Hong R; Lu H; Ji H; Lu L; Li Y
    Oncotarget; 2017 Jan; 8(2):3454-3470. PubMed ID: 27966449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.